JP
Jason Pitofsky (VP Controller) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Regeneron Pharmaceuticals, Inc. (REGN). The largest single filing was $3.8M of REGN (4,027 sh across 7 lots, as filed), executed Nov 4. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
3
0 buys · 3 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$5.2M
shares × price, as filed
Last traded
Nov 4
Filed Nov 6
Median ADV $702.3M across their filed names
Open performance→Volume by month
Buys $0
Sells $5.5M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
REGNRecent filings
REGNSALE
Regeneron Pharmaceuticals, Inc.
View filing →
$3.8M4,027 sh across 7 lots
Exec Nov 4
Filed Nov 6 · 4:01 PM ET REGNSALE Regeneron Pharmaceuticals, Inc. View filing → $1.4M
1,824 sh across 5 lots
Exec Feb 9
Filed Feb 11 · 5:30 PM ET REGNSALE Regeneron Pharmaceuticals, Inc. View filing → $281K
431 sh × $651.43
Exec Nov 7 2025
Filed Nov 10 2025 · 5:30 PM ET